These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30082483)

  • 41. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
    Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
    Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
    Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical mouse models of hepatocellular carcinoma: An overview and update.
    Gu CY; Lee TKW
    Exp Cell Res; 2022 Mar; 412(2):113042. PubMed ID: 35101391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice.
    Umeda T; Yamamoto T; Kajino K; Hino O
    Int J Oncol; 2000 Jun; 16(6):1133-6. PubMed ID: 10811985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma.
    Allain C; Angenard G; Clément B; Coulouarn C
    Cancer Res; 2016 Nov; 76(21):6374-6381. PubMed ID: 27634755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
    Shen J; Tsoi H; Liang Q; Chu ES; Liu D; Yu AC; Chan TF; Li X; Sung JJ; Wong VW; Yu J
    Oncogene; 2016 Dec; 35(49):6271-6280. PubMed ID: 27132506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
    Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
    J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
    Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
    Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.
    Colak D; Chishti MA; Al-Bakheet AB; Al-Qahtani A; Shoukri MM; Goyns MH; Ozand PT; Quackenbush J; Park BH; Kaya N
    Mol Cancer; 2010 Jun; 9():146. PubMed ID: 20540791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice.
    Teoh NC; Dan YY; Swisshelm K; Lehman S; Wright JH; Haque J; Gu Y; Fausto N
    Hepatology; 2008 Jun; 47(6):2078-88. PubMed ID: 18506893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
    Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
    Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C; Bhavani K; Chisari FV
    Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC.
    Ritorto MS; Rhode H; Vogel A; Borlak J
    Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice.
    Wang Y; Cui F; Lv Y; Li C; Xu X; Deng C; Wang D; Sun Y; Hu G; Lang Z; Huang C; Yang X
    Hepatology; 2004 Feb; 39(2):318-24. PubMed ID: 14767984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
    Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
    Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
    Castven D; Fischer M; Becker D; Heinrich S; Andersen JB; Strand D; Sprinzl MF; Strand S; Czauderna C; Heilmann-Heimbach S; Roessler S; Weinmann A; Wörns MA; Thorgeirsson SS; Galle PR; Matter MS; Lang H; Marquardt JU
    Oncotarget; 2017 Jul; 8(30):48688-48700. PubMed ID: 28415775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice.
    Li L; Qian M; Chen IH; Finkelstein D; Onar-Thomas A; Johnson M; Calabrese C; Bahrami A; López-Terrada DH; Yang JJ; Tao WA; Zhu L
    Am J Pathol; 2018 Mar; 188(3):656-671. PubMed ID: 29248454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.